Mobile Site ›
Print Friendly View

Test ID: C2729    
Breast Carcinoma-Associated Antigen (CA 27.29), Serum

Secondary ID A test code used for billing and in test definitions created prior to November 2011

200814

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

FDA-approved CA 27.29 for serial testing in women with prior stage II or III breast cancer who are clinically free of disease

 

Predicting early recurrence of disease in women with treated carcinoma of the breast

 

As an indication that additional tests or procedures should be performed to confirm recurrence of breast cancer

Method Name A short description of the method used to perform the test

Chemiluminometric Immunoassay

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

Breast Carcinoma Assoc Ag(CA 27.29)

Aliases Lists additional common names for a test, as an aid in searching

Biomira Truquant BR
Breast Cancer Tumor Markers
Breast Carcinoma
Cancer Antigen 27.29 (CA 27.29)
MAM 6
Milk Mucin
CA2729